| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | latanoprost (Monopost®) |
| Formulation | 50 micrograms/ml eye drops |
| Reference number | 1970 |
| Indication | Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension |
| Company | Spectrum Thea Pharmaceuticals |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 25/01/2013 |